Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Pradaxa Trial Dates in MDL Pushed Back to September 2014 March 10, 2014 Austin Kirk Add Your Comments The first of four Pradaxa lawsuits scheduled for early trial dates in the federal court system will now begin in September 2014, after the U.S. District judge presiding over the litigation delayed the start of the first case about one month. U.S. Distict Judge David R. Herndon is currently presiding over more than 2,000 lawsuits pending against Boehringer Ingelheim in the federal court system, which all involve similar allegations that the drug maker failed to provide adequate warnings about the risk of Pradaxa bleeding injuries. As part of the coordinated pretrial proceedings in the cases, Judge Herndon previously selected four cases for early trial dates, which were expected to begin between August 2014 and February 2015 in the U.S. District Court for the Southern District of Illinois. Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a case management order (PDF) issued March 5, Judge Herndon pushed back the trial dates about 30 days and established a new order for the cases to go before juries. Jury selections in for lawsuit filed by Suzanne Mackiewicz will now begin on September 8, 2014, with opening statements expected to begin on September 15. Her case involves a wrongful death claim on behalf of her father, Malachy Higgins. The second bellwether trial will address a claim filed by Georgia Primus and is scheduled to begin on December 1, 2014. The third bellwether trial involves a wrongful death lawsuit by Adalaine Nancy Kohn, whose husband died after a Pradax bleeding event. Originally it was the scheduled to be the second case to go to trial, but it will now go before a jury on February 17, 2015. The fourth and final bellwether trial will involve a case brought by Helen Jean and John Edwards Hawkins, which is scheduled to begin on March 23, 2015. All of the lawsuits contain similar allegations that the manufacturer failed to adequately warn consumers and the medical community about the potential bleeding side effects of Pradaxa, as well as the lack of an antidote that would allow doctors to stop the blood thinning effects of the medication. As a result, many doctors did not have a plan for counteracting the drug. Pradaxa Bleeding Risks Pradadxa (dabigatran) is a relatively new anticoagulant therapy that was approved by the FDA in October 2010. It was the first member of a new class of medications that are promoted as superior alternatives to warfarin, also known by the brand name Coumadin, for stroke prevention. However, shortly after its introduction, Pradaxa began to rack up a record number of adverse event reports after patients experienced uncontrolled bleeding events. Warfarin, sold under the brand name Coumadin, has been the go-to anticoagulant for decades. While Pradaxa was promoted as easier to use, because it requires less monitoring by the doctor during treatment, concerns have emerged about the lack of an effective reversal agent to stop the blood thinning effects of the medication. Unlike warfarin, which can be quickly reversed with a dose of vitamin K and plasma, there is no available reversal agent for Pradaxa. While some studies have shown that the chances of bleeding may be about the same with the two drugs, evidence continues to emerge highlighting how Pradaxa bleeding problems may pose a more serious risk, since hemorrhages are typically harder to stop. There have been thousands of reports of injuries and hundreds of deaths associated with Pradaxa use since it was introduced in October 2010. During the first full year the drug was on the market in the United States, the Institute for Safe Medication Practices (ISMP) found that adverse event reports involving Pradaxa problems surpassed all other medications regularly monitored by the group. FDA received at least 3,781 reports involving serious injuries associated with the use of Pradaxa during 2011, including 2,367 reports of hemorrhage and 542 patient deaths. These early Pradaxa trials are being closely watched by lawyers involved in the litigation, as they may help gauge how juries will respond to certain evidence and testimony that is likely to be similar to what is offered in other cases. Following the bellwether trials, if the parties do not make progress towards reaching Pradaxa settlement agreements, it is possible that Judge Herndon will begin remanding hundreds of cases back to U.S. District Courts where they were originally filed for separate trial dates. Tags: Bleeding, Blood Thinners, Boehringer Ingelheim, Coumadin, Internal Bleeding, Pradaxa, Warfarin Image Credit: | More Pradaxa Lawsuit Stories Jury Awards $540K in Pradaxa Trial Against Boehringer Ingelheim May 21, 2019 Paragard IUD Lawsuit Dismissed on Summary Judgment February 25, 2019 Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: 2 days ago) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025) Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 3 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025) Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 4 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018
Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: 2 days ago) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 3 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025)
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 4 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)